Methimazole-induced intrahepatic cholestasis;Colestasis intrahepática por metimazol

Endocrinologia y Nutricion

Volumn 50, Issue 8, 2003, Pages 345-347

  Perez Carrerasa M ^a   Lamela, M P ^a   Galera, G ^a   Solis Herruzoa J A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cholestasis; Hepatotoxicity; Hyperthyroidism; Methimazole

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; LIOTHYRONINE; THIAMAZOLE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; ECHOGRAPHY; EXOPHTHALMOS; FEMALE; GOITER; HUMAN; HYPERTHYROIDISM; INTRAHEPATIC CHOLESTASIS; LIVER TOXICITY; MYXEDEMA; OBSTRUCTIVE JAUNDICE; THYROID SCINTISCANNING;

EID: 0242557647     PISSN: 15750922     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1575-0922(03)74548-3     Document Type: Article

References (25)

1. Woeber K. The year in Review: The Thyroid. An Intern Med 1990;131:959-62.
2. Woeber K. Update on the management of hyperthyroidism and hypothyroidism. Arch Intern Med 2000;160:1067-71.
3. Singer P, Cooper D, Levy E, Ladenson P, Braverman L, Daniels G, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995;273:808-12.
4. Lazarous JH. Hyperthyroidism. Lancet 1997;349:339-43.
5. Weetman AP. Graves' disease. N Engl J Med 2000;343:1236-48.
6. Cooper DS. Antithyroid drugs. N Engl J Med 1984;311:1353-62.
7. Cooper DS, Goldminz D, Levin AA, Ladenson PW, Daniels GH, Molitch ME, et al. Agranulocytosis associated with antithyroid drugs. Effects of patient age and drug use. Ann Intern Med 1983;98:26-9.
8. Okamura K, Ikenoue H, Shiroozu A, Sato K, Yoshinari M, Fujishima M. Reevaluation of the effects of methylmercaptoimidazole and propylthiouracil in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab 1987;65:719-23.
9. Homsanit M, Sriussadaporn S, Vannasaeng S, Peerapatdit T, Nitiyanant W, Vichayanrat A. Efficacy of a single daily dosage of methimazole vs. propylthiouracil in the induction of the euthyroidism. Clin Endocrinol (Oxf) 2001;54:385-90.
10. Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS. Adverse effects related to thionamide drugs and their dose regimen. Am J Med Sci 1989;297:216-9.
11. Solá E, Morillas C, Peña H, Muñoz ML, Morillas J, Hernández A. Hepatitis colestásica por metimazol. Endocrinol Nutr 2002;49:127-9.
12. Woeber K. Methimazole-induced hepatotoxicity. Endocr Pract 2002;8:222-4.
13. Arab D, Malatjalian D, Rittmaster R. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. J Clin Endocrinol Metab 1995;80:1083-5.
14. Findor J, Bruch E, Sorda J, Jury R. Ictericia por metimazol. Acta Gastroent Latinoamer 1991;21:115-9.
15. Schwab GP, Wetscher GJ, Vogl W, Redmond E. Methimazole-induced cholestatic liver injury, mimicking sclerosing cholangitis. Langenbeeks Arch Chir 1996;381:225-7.
16. Schmidt G, Borsch G, Muller KM, Wegener M. Methimazole-associated cholestatic liver injury: case report and brief literature review. Hepatogastroenterology 1986;33:244-6.
17. Stanley M, Astwood EB. 1-Methyl-2 mercaptoimidazole: an antithyroid compound highly active in man. Endocrinology 1949;44:588-9.
18. Larrey D, Erlinger S. Drug-induced cholestasis. Clin Gastoenterol 1988;2:423-52.
19. Huang MH, Li KL, Wei JS, Wu SS, Fan KD, Liaw YF. Sequential liver and bone biochemical changes in hyperthyroidism: prospective controlled follow-up study. Am J Gastroenterol 1994;89:1071-6.
20. Solá J, Pardo-Mindan FJ, Zozaya J. Liver changes in patients with hyperthyroidism. Liver 1991;11:193-7.
21. Greenberg NJ, Milligan FD, DeGroot LJ, Isselbacher KJ. Jaundice and thyrotoxicosis in the absence of congestive heart failure. Am J Med 1964;36:840-6.
22. Blom H, Stolk J, Schreuder HB, Von Blomberg-van der Flier M. A case of carbimazole-induced intrahepatic cholestasis: an immune mediated reaction? Arch Intern Med 1985;145:1513-5.
23. Larrey D. Drug-induced liver diseases. J Hepatol 2000;32:77-8.
24. Pirmohamed M, Kitteringham NR, Kevin-Park B. The role of active metabolites in drug toxicity. Drug Saf 1994;11:114-44.
25. Benichou C. For the Council for International Organization of Medical Sciences (CIOMS). Consensous-Criteria for drug-in-duced liver disorders. Report of an International Consensus Meeting. J Hepatol 1990;11:272-6.